BioAmber Inc.
BIOA.WS
BIOA.WS was delisted on the 3rd of May, 2017.
12 hedge funds and large institutions have $4.1M invested in BioAmber Inc. in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 12 → 12 (0)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
59% less capital invested
Capital invested by funds: $9.92M → $4.1M (-$5.82M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$4.33K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$75 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Moore Capital Management
New York
|
-$37.4K |
| 2 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
-$32.5K |
| 3 |
Barclays
London,
United Kingdom
|
-$828 |
| 4 |
JGC
J. Goldman & Co
New York
|
-$149 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WRF
1
Waddell & Reed Financial
Overland Park,
Kansas
| $2.2M | – | – | – |
|
|
ACPU
2
Arrowgrass Capital Partners (US)
Dover,
Delaware
| $648K | -$32.5K | -43,498 | -6% |
|
|
PRCM
3
Pine River Capital Management
Minnetonka,
Minnesota
| $430K | +$4.33K | +5,800 | +1% |
|
|
MCM
4
Moore Capital Management
New York
| $204K | -$37.4K | -50,000 | -16% |
|
|
SFM
5
Soros Fund Management
New York
| $155K | – | – | – |
|
6
Millennium Management
New York
| $120K | – | – | – |
|
|
LCS
7
Levin Capital Strategies
New York
| $115K | – | – | – |
|
|
SCM
8
Saba Capital Management
New York
| $103K | – | – | – |
|
|
JGC
9
J. Goldman & Co
New York
| $96K | -$149 | -200 | -0.2% |
|
10
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $31K | – | – | – |
|
|
11
Barclays
London,
United Kingdom
| – | -$828 | -1,108 | -98% |
|
|
U
12
UBS
Zurich,
Switzerland
| – | +$75 | +100 | +30% |
|
BIOA.WS Hedge Fund Activity: Q3 2013 in Review
12 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA.WS) for Q3 2013, worth a combined $4.1M — down 59% from $9.92M a quarter earlier.
Fund positioning in BIOA.WS was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was Pine River Capital Management, adding an estimated $4.33K. The largest seller was Moore Capital Management, cutting an estimated $37.4K.
- 12 institutional investors held BioAmber Inc. (BIOA.WS) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $4.1M of BioAmber Inc. stock for Q3 2013, down 59% quarter-over-quarter.
- 0 funds opened new BioAmber Inc. positions in Q3 2013 and 0 closed out.
- The largest BioAmber Inc. buyer in Q3 2013 was Pine River Capital Management, an estimated $4.33K added.
- The largest BioAmber Inc. seller in Q3 2013 was Moore Capital Management, an estimated $37.4K sold.
Based on aggregated 13F filings for Q3 2013.